title: CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis.
authors.affiliation: Hematology division, A.O. Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: M C
authors.initials: MC
authors.lastname: Finazzi
authors.affiliation: Research Foundation, A.O. Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Carobbio
authors.affiliation: Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Cervantes
authors.affiliation: Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
authors.forename: I M
authors.initials: IM
authors.lastname: Isola
authors.affiliation: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.affiliation: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Guglielmelli
authors.affiliation: Hematology division, A.O. Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Rambaldi
authors.affiliation: Hematology division, A.O. Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Finazzi
authors.affiliation: Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Barosi
authors.affiliation: 1] Hematology division, A.O. Papa Giovanni XXIII, Bergamo, Italy [2] Research Foundation, A.O. Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Barbui
mesh_terms: D037282:Calreticulin / Q000235:genetics*; D004252:DNA Mutational Analysis; D005060:Europe; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation; D055728:Primary Myelofibrosis / Q000150:complications / Q000175:diagnosis / Q000235:genetics*; D053628:Receptors, Thrombopoietin / Q000235:genetics*; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000235:genetics; D013927:Thrombosis / Q000150:complications / Q000235:genetics; D016896:Treatment Outcome
chemical_list: D037282:Calreticulin; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2